235 related articles for article (PubMed ID: 25329832)
1. Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity.
Tosic V; Thomas DL; Kranz DM; Liu J; McFadden G; Shisler JL; MacNeill AL; Roy EJ
PLoS One; 2014; 9(10):e109801. PubMed ID: 25329832
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.
Tang B; Guo ZS; Bartlett DL; Yan DZ; Schane CP; Thomas DL; Liu J; McFadden G; Shisler JL; Roy EJ
Clin Cancer Res; 2020 May; 26(9):2216-2230. PubMed ID: 32019860
[TBL] [Abstract][Full Text] [Related]
3. An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.
Ma R; Lu T; Li Z; Teng KY; Mansour AG; Yu M; Tian L; Xu B; Ma S; Zhang J; Barr T; Peng Y; Caligiuri MA; Yu J
Cancer Res; 2021 Jul; 81(13):3635-3648. PubMed ID: 34006525
[TBL] [Abstract][Full Text] [Related]
4. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
[TBL] [Abstract][Full Text] [Related]
5. A cautionary note on the selectivity of oncolytic poxviruses.
Tang B; Guo ZS; Bartlett DL; Liu J; McFadden G; Shisler JL; Roy EJ
Oncolytic Virother; 2019; 8():3-8. PubMed ID: 30805315
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and expression analysis of interleukin 15 (IL15) and interleukin-15 receptor subunit alpha (IL15Rα) in dojo loach (Misgurnus anguillicaudatus): Their salient roles during bacterial, parasitic and fungal infection.
Chen X; Kong W; Yu Y; Dong S; Huang Z; Yu W; Xu J; Luo Y; Wang Q; Xu Z
Mol Immunol; 2018 Nov; 103():293-305. PubMed ID: 30343118
[TBL] [Abstract][Full Text] [Related]
7. A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy.
Xu H; Buhtoiarov IN; Guo H; Cheung NV
Oncoimmunology; 2021 Mar; 10(1):1893500. PubMed ID: 33763293
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J
Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model.
Niu Z; Bai F; Sun T; Tian H; Yu D; Yin J; Li S; Li T; Cao H; Yu Q; Wu Y; Ren G; Li D
Technol Cancer Res Treat; 2015 Oct; 14(5):607-15. PubMed ID: 24645750
[TBL] [Abstract][Full Text] [Related]
10. Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade.
Kowalsky SJ; Liu Z; Feist M; Berkey SE; Ma C; Ravindranathan R; Dai E; Roy EJ; Guo ZS; Bartlett DL
Mol Ther; 2018 Oct; 26(10):2476-2486. PubMed ID: 30064894
[TBL] [Abstract][Full Text] [Related]
11. Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation.
Schmid AS; Neri D
PLoS One; 2019; 14(7):e0219313. PubMed ID: 31348785
[TBL] [Abstract][Full Text] [Related]
12.
Giehl E; Kosaka H; Liu Z; Feist M; Kammula US; Lotze MT; Ma C; Guo ZS; Bartlett DL
Front Immunol; 2021; 12():610042. PubMed ID: 33679747
[TBL] [Abstract][Full Text] [Related]
13. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.
Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S
Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794
[TBL] [Abstract][Full Text] [Related]
14. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
Sanseviero E; O'Brien EM; Karras JR; Shabaneh TB; Aksoy BA; Xu W; Zheng C; Yin X; Xu X; Karakousis GC; Amaravadi RK; Nam B; Turk MJ; Hammerbacher J; Rubinstein MP; Schuchter LM; Mitchell TC; Liu Q; Stone EL
Cancer Immunol Res; 2019 Aug; 7(8):1371-1380. PubMed ID: 31239316
[TBL] [Abstract][Full Text] [Related]
15. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.
Zhang H; Cui Y; Voong N; Sabatino M; Stroncek DF; Morisot S; Civin CI; Wayne AS; Levine BL; Mackall CL
J Immunother; 2011 Mar; 34(2):187-95. PubMed ID: 21304401
[TBL] [Abstract][Full Text] [Related]
16. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
Gaston DC; Odom CI; Li L; Markert JM; Roth JC; Cassady KA; Whitley RJ; Parker JN
PLoS One; 2013; 8(11):e81768. PubMed ID: 24312353
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Antitumor Activity of a Recombinant IL7/IL15 Hybrid Cytokine in Mice.
Song Y; Liu Y; Hu R; Su M; Rood D; Lai L
Mol Cancer Ther; 2016 Oct; 15(10):2413-2421. PubMed ID: 27474151
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy to produce high level and high purity of bioactive IL15 fusion proteins from mammalian cells.
Huang H; Luo Y; Baradei H; Liu S; Haenssen KK; Sanglikar S; Kumar S; Cini J
Protein Expr Purif; 2018 Aug; 148():30-39. PubMed ID: 29596991
[TBL] [Abstract][Full Text] [Related]
19. Essential role of interleukin-15 receptor in normal anxiety behavior.
Wu X; He Y; Hsuchou H; Kastin AJ; Rood JC; Pan W
Brain Behav Immun; 2010 Nov; 24(8):1340-6. PubMed ID: 20600810
[TBL] [Abstract][Full Text] [Related]
20. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.
Opgenorth A; Graham K; Nation N; Strayer D; McFadden G
J Virol; 1992 Aug; 66(8):4720-31. PubMed ID: 1629952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]